GEN News Highlights

Presidential Panel Expected to Sort Out Ethics of Clinical Sequencing, According to GEN Poll

(Page
1
of
1)

Nearly two-thirds of respondents to a recent GEN poll are optimistic that the U.S. Presidential Commission for the Study of Bioethical Issues will prove either very helpful (34.1%) or somewhat helpful (31.8%) in setting guidelines for the ethical use of whole genome sequencing in the clinical setting. Another 29.5% said the presidential panel would prove to be “not very” help.

The bioethics commission is grappling with many ethical issues arising from the potential of increased use of whole genome sequencing in clinical care. The panel plans to discuss its recommendations publicly and come to consensus views at its August meeting. The recommendations are to be finalized in a report to President Barack Obama that is expected to be completed this fall.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.